Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuromodulation ; 24(3): 499-506, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33469972

ABSTRACT

OBJECTIVES: High-frequency 10 kHz spinal cord stimulation (10 kHz-SCS) has achieved analgesia superior to traditional SCS in a number of studies. However, there is concern regarding long-term outcomes of 10 kHz-SCS. Prior work has suggested that explant rates are higher with 10 kHz-SCS. Our primary objective was to determine the explant rate of 10 kHz-SCS in a large patient cohort from multiple centers followed for at least 12 months after implant surgery. MATERIALS AND METHODS: We performed a retrospective chart review of all patients who received a 10 kHz-SCS implant before July 1, 2019. We abstracted patient demographics, implant date, primary site of pain, implant indication, explant date, and reason for explant. A total of 744 patients were included in the study analysis. RESULTS: Average age of the overall cohort was 65.53 years and 407 (54.7%) were women. Average follow-up for all patients was 793 days. There were a total of 76 explants (10.2%). The most common reason for explant was loss of efficacy, which accounted for 39 explants (51.3% of total explants, 5.2% of overall cohort). Female sex and radiculopathy as the SCS indication were associated with statistically significant decreased risk of 10 kHz-SCS explant. CONCLUSIONS: We found 10 kHz-SCS explant rates to be similar to prior reported explant rates for traditional SCS devices. Patient-related factors including female sex and radiculopathy as the primary SCS indication may be protective factors against explantation.


Subject(s)
Chronic Pain , Spinal Cord Stimulation , Aged , Chronic Pain/therapy , Device Removal , Female , Humans , Male , Pain Management , Retrospective Studies
2.
Anesth Analg ; 105(6): 1561-3, table of contents, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18042847

ABSTRACT

Primary amyloidosis is a result of proliferation of a population of plasma cells that leads to an increased secretion of monoclonal immunoglobulins (amyloid). Amyloid protein infiltrates increase capillary fragility. Such capillaries can burst, even after minor stress, resulting in periorbital hemorrhage. We describe a 64-yr-old man with primary amyloidosis who underwent general anesthesia. His eyes were gently closed with tape. Upon removal of the tape bilateral periorbital purpura was noted. All coagulation studies were normal. The periorbital hemorrhage was attributed to amyloidosis-induced capillary fragility.


Subject(s)
Amyloidosis/pathology , Anesthesia, General/adverse effects , Ecchymosis/pathology , Eye Hemorrhage/pathology , Eyelids/pathology , Amyloidosis/complications , Amyloidosis/genetics , Ecchymosis/etiology , Ecchymosis/genetics , Eye Hemorrhage/etiology , Eye Hemorrhage/genetics , Hemorrhage/etiology , Hemorrhage/genetics , Hemorrhage/pathology , Humans , Male , Middle Aged , Orbit/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...